NCT00116155View on ClinicalTrials.gov

Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

CV787 (CG7870)

Sponsors

Lead Sponsor

Cell Genesys
All Listed Sponsors
lead

Cell Genesys

INDUSTRY

NCT00116155 - Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter